Alpa Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

52.30 +1.53 ▲3.0%

29 March 2023, 04:01:00 PM
Volume: 4,745

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alpalabs.in
Market Cap 110.04 Cr.
Enterprise Value(EV) 116.35 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.15 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 24.27 Trailing Twelve Months Ending 2022-12
Industry PE 32.00 Trailing Twelve Months Ending 2022-12
Book Value / Share 56.48 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.93 Calculated using Price: 52.30
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.10 Cr. 21,040,600 Shares
FaceValue 10
Company Profile
Alpa Laboratories, incorporated in 1988, is engaged in the business of manufacturing pharmaceutical products. In 1967, the company started its journey as a partnership concern with Purushottam R Patel, M S Chawla and Pravin C Shah as the founding partners. Later on March 18, 1988 the company became a private limited company and a decade later it became a public limited enterprise.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.01%
1 Week
-4.42%
1 Month
-8.25%
3 Month
-15.92%
6 Month
-11.88%
1 Year
-24.42%
2 Year
+43.29%
5 Year
+34.45%
10 Year
+557.86%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -5.84 -1.60 7.61 2.68 2.92 1.03 1.86 6.97 12.29
Return on Capital Employed (%) -2.54 -0.89 9.61 6.59 5.47 3.26 3.09 10.42 16.81
Return on Assets (%) -4.07 -1.10 4.99 1.86 2.29 0.84 1.54 5.56 9.53

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 88 87 93 95 98 98 100 108 122 114
Non Curr. Liab. 6 0 1 0 0 0 -1 0 5 12
Curr. Liab. 32 41 52 30 23 22 21 33 29 30
Minority Int.
Equity & Liab. 127 128 146 125 121 121 120 140 155 157
Non Curr. Assets 74 16 27 20 23 27 25 19 16 16
Curr. Assets 53 113 119 105 98 94 95 121 139 140
Misc. Exp. not W/O
Total Assets 127 128 146 125 121 121 120 140 155 157

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 57 57 54 63 63 78 86 98 112 88
Other Income 1 3 6 5 5 5 3 4 11 12
Total Income 57 61 59 69 68 83 89 102 123 101
Total Expenditure -51 -55 -47 -56 -59 -77 -83 -90 -102 -89
PBIDT 6 6 12 12 9 6 6 12 21 12
Interest -2 -2 -1 -2 -1 -1 0 0 0 0
Depreciation -9 -6 -1 -3 -3 -3 -3 -1 -2 -1
Taxation 0 1 -3 -3 -2 -2 -1 -4 -5 -5
Exceptional Items -1 -2
PAT -5 -1 7 3 3 1 2 7 14 5
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -5 -1 7 3 3 1 2 7 14 5
Adjusted EPS -2 -1 3 1 1 0 1 3 7 2

Cash Flow View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 8 -2 -22 17 -13 -1 18 -2 2
Cash Fr. Inv. -2 37 -8 -2 -11 -15 -11 6 -16
Cash Fr. Finan. 4 7 -6 -15 9 -5 -1 0 5
Net Change 10 42 -36 0 -15 -20 5 4 -8
Cash & Cash Eqvt 10 53 17 37 21 1 6 11 3

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 56.66 56.66 56.66 56.66 56.66 57.29 57.29 57.29 57.29
Public 43.34 43.34 43.34 43.34 43.34 42.71 42.71 42.71 42.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 14 Feb 2023
Financial Results Of The Company For Quarter And Nine Months Ended On 31St December 2022.
Alpa Laboratories Limited has submitted the Un-Audited Standalone & Consolidated Financial Results of the Company for Quarter and Nine Months ended on 31st December 2022.
Fri, 03 Feb 2023
Board Meeting Intimation for The Quarter Ended On 31St December 2022
ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter ended on 31st December 2022.
Sat, 21 Jan 2023
Clarification sought from Alpa Laboratories Ltd
The Exchange has sought clarification from Alpa Laboratories Ltd on January 20 2023 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

The reply is awaited.

Technical Scans View Details >>

Tue, 28 Mar 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,142.55 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 75,408.82 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,473.23 2,818.70 +0.5%
Cipla Ltd. 71,800.08 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,246.53 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,239.05 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,031.17 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.01 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.72 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.07 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.21 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.27 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.79 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.27 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.43 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.07 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.84 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Alpa Laboratories Ltd.

What is Alpa Lab share price?
Can I buy Alpa Lab shares now?
What is the Market Cap of Alpa Lab?
What are the key metrics to analyse Alpa Lab?
What is the 52 Week High and Low of Alpa Lab?
What is the trend of Alpa Lab share price?